Yang, F., Mao, Y., Huang, H., Luo, W., Liu, L., & Chen, W. (2025). The efficacy and safety of regorafenib/fruquintinib combined with PD-1/PD-L1 for metastatic colorectal cancer. Frontiers in Immunology, 16, . https://doi.org/10.3389/fimmu.2025.1579293
Chicago-referens (17:e uppl.)Yang, Fan, Ying Mao, Hanyu Huang, Wen Luo, Li Liu, och Wenzhi Chen. "The Efficacy and Safety of Regorafenib/fruquintinib Combined with PD-1/PD-L1 for Metastatic Colorectal Cancer." Frontiers in Immunology 16 (2025). https://doi.org/10.3389/fimmu.2025.1579293.
MLA-referens (9:e uppl.)Yang, Fan, et al. "The Efficacy and Safety of Regorafenib/fruquintinib Combined with PD-1/PD-L1 for Metastatic Colorectal Cancer." Frontiers in Immunology, vol. 16, 2025, https://doi.org/10.3389/fimmu.2025.1579293.
